{"id":"W3161919645","doi":"10.1038/s41375-021-01261-x","title":"Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Corporation","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Anemia; Adverse effect; Dosing; Internal medicine; Polycythemia vera; Gastroenterology; Hemoglobin; Phases of clinical research; Surgery; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002057963,0.0009502835,0.002048554,0.000361135,0.0002413336,0.001304241,0.0008369185,0.001279747,0.002615105],"category_scores_gemma":[0.001415426,0.000477582,0.001639111,0.0002241354,0.0005328755,0.000851248,0.0004257705,0.003101243,0.0006709651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000668769,"about_ca_system_score_gemma":0.0006362413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003269665,"about_ca_topic_score_gemma":0.0008691582,"domain_scores_codex":[0.9994803,0.000272325,0.00002307799,0.00008108639,0.00007093123,0.00007236037],"domain_scores_gemma":[0.9994281,0.0001402119,0.0002002566,0.00005747924,0.00005088738,0.0001230299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7311663,0.05469152,0.004628176,0.00114126,0.002027628,0.0002531067,0.000278718,0.004651579,0.03761009,0.0003938977,0.005998439,0.1571594],"study_design_scores_gemma":[0.6143742,0.3617181,0.01196711,0.00007902454,0.0007643556,0.0005235499,0.00004113838,0.003655014,0.003022764,0.000193121,0.003593325,0.00006824117],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914106,0.003929637,0.0006819078,0.0006149019,0.0001143616,0.0007745867,0.0007444674,0.0001218411,0.001607725],"genre_scores_gemma":[0.9902023,0.001826227,0.001787799,0.001058521,0.0002643285,0.001234965,0.00185476,0.00003304467,0.001738072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002615105,"threshold_uncertainty_score":0.01088369,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03425455265126314,"score_gpt":0.3173339949928264,"score_spread":0.2830794423415633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}